QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
LON:QP

Quantum Pharma (QP) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
446,328 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
QP stock logo

About Quantum Pharma Stock (LON:QP)

Quantum Pharma Plc is a pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesaler, hospital and homecare markets. The Company's core business is the manufacture, procurement and supply of unlicensed medicines (specials) and special obtains to the United Kingdom pharmacy chains. It operates through three segments: Specials; Niche Pharmaceuticals (Niche), and Medication Adherence (MA). The Specials segment engages in the manufacture, source and supply specials to pharmacies, pharmaceutical wholesalers, hospitals, and other specials suppliers throughout the United Kingdom and overseas. The Niche Pharmaceuticals segment develops and supplies nice pharmaceuticals, provides development and regulatory services, and out-licenses products and dossiers to third parties across Europe. The Medication Adherence segment provides products and services designed to provide adherence to medication regimes.

QP Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Computing's quantum shift
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
The race to develop quantum computers
Debunking The Top 5 Quantum Computing Myths
How Quantum Safe Is Your Business?
Quantum Pharma PLC (QP)
See More Headlines
Receive QP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Chris Rigg
    Chief Executive Officer, Director
  • Gerard Thomas Murray
    Chief Financial Officer, Director
  • George Liolios
    Managing Director at Lamda
  • Brian Fisher
    Joint Managing Director - Special Division
  • Nicola Massey
    Managing Director - Niche Pharmaceuticals Division
  • Andrew Matthews
    Joint Managing Director - Special Division
  • Ian Pearce
    Managing Director - Medication Adherence Division
  • Craig Swinhoe
    Group Legal and Projects Director and Company Secretary
  • Ian Roy Johnson
    Non-Executive Chairman of the Board
  • Christopher Harwood Bernard Mills
    Non-Executive Director

QP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Quantum Pharma own?
How do I buy shares of Quantum Pharma?

Shares of QP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:QP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners